-
Risks and benefits for patients with relapsed or refractory diffuse large B-cell lymphoma in early-phase clinical trials: a systematic review and meta-analysis
Spanjaart, A. M., Bakker, M., de Vries, R., Hutten, B. A., van Nieuwenhuijzen, N., Minnema, M. C., Kuipers, M. T. & Kersten, M. J., 1 May 2026, In: The Lancet Haematology. 13, 5, p. e297-e314Research output: Contribution to Journal › Article › Academic › peer-review
-
Perspectives on T-cell engaging therapies in relapsed/refractory indolent non-Hodgkin lymphoma
Bakker, M., Kuipers, M. T., Kersten, M. J., Tonino, S. H. & Serroukh, Y. I. M., 1 Sept 2025, In: Current Opinion in Oncology. 37, 5, p. 393-400 8 p., 10.1097/CCO.0000000000001160.Research output: Contribution to Journal › Review article › Academic › peer-review
- All publications
